P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

DAYBUE – Breaking News

Approves Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE (trofinetide) for the Treatment of Rett Syndrome.  DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare neurodevelopmental disorder. We recognize the… Read More

2025 Calendars

Order your Copy Today! We are beyond excited to share the 2025 O.R.S.A. Calendar, where art, resilience, and community come together form coast to coast in the most beautiful way! Created by individuals with Rett syndrome and their amazing… Read More